Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

  • Ramiro Pascual, Laura
  • Faura Llorens, Julia
  • Garcia Rodriguez, Paula
  • Ma, Feifei
  • Martín Castel, Luna
  • Canals Suris, Francesc
  • Montaner Villalonga, Joan
  • Rosell Novel, Anna
  • Simats Oriol, Alba
Diabetes; Proteome; Sex, Diabetis; Proteoma; Sexe, Diabetes; Proteoma; Sexo, Ischemic stroke is a major cause of death and disability worldwide. Translation into the clinical setting of neuroprotective agents showing promising results in pre-clinical studies has systematically failed. One possible explanation is that the animal models used to test neuroprotectants do not properly represent the population affected by stroke, as most of the pre-clinical studies are performed in healthy young male mice. Therefore, we aimed to determine if the response to cerebral ischemia differed depending on age, sex and the presence of comorbidities. Thus, we explored proteomic and transcriptomic changes triggered during the hyperacute phase of cerebral ischemia (by transient intraluminal middle cerebral artery occlusion) in the brain of: (1) young male mice, (2) young female mice, (3) aged male mice and (4) diabetic young male mice. Moreover, we compared each group's proteomic and transcriptomic changes using an integrative enrichment pathways analysis to disclose key common and exclusive altered proteins, genes and pathways in the first stages of the disease. We found 61 differentially expressed genes (DEG) in male mice, 77 in females, 699 in diabetics and 24 in aged mice. Of these, only 14 were commonly dysregulated in all groups. The enrichment pathways analysis revealed that the inflammatory response was the biological process with more DEG in all groups, followed by hemopoiesis. Our findings indicate that the response to cerebral ischemia regarding proteomic and transcriptomic changes differs depending on sex, age and comorbidities, highlighting the importance of incorporating animals with different phenotypes in future stroke research studies., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by the European Regional Development Fund (FEDER). Neurovascular Research Laboratory takes part in the Spanish stroke research network RICORS-ICTUS. L.R is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro Pascual, Laura
  • Quintana Luque, Manuel
  • Garcia Rodriguez, Paula
  • Santamarina Pérez, Estevo
  • Alvarez Sabin, José
  • Bustamante Rangel, Alejandro
  • Montaner Villalonga, Joan
  • Abraira del Fresno, Laura
Biomarcador; Endostatina; Accident cerebrovascular isquèmic, Biomarcador; Endostatina; Accidente cerebrovascular isquémico, Biomarker; Endostatin; Ischemic stroke, Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z-scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin > quartile 2, tumor necrosis factor receptor-1 (TNF-R1) > quartile 2, and interleukin (IL)-6 > quartile 2. The risk of mortality when these three biomarkers were combined increased up to 69%. The addition of the biomarkers to clinical predictors improved the discrimination (integrative discriminative improvement (IDI) 0.022 (0.007–0.048), p < 0.001). Moreover, endostatin > quartile 3 was an independent predictor of mortality due to stroke. Altogether, endostatin, TNF-R1, and IL-6 circulating levels may aid in long-term mortality prediction after stroke., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by La Fundació La Marató (Reg. 84/240 proj. 201702). Neurovascular Research Laboratory takes part in the Spanish stroke research network INVICTUS+ (RD16/0019/0021). L.R. is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management

  • Ramiro, Laura|||0000-0002-4121-4609
  • Simats Oriol, Alba|||0000-0002-0415-1135
  • García-Berrocoso, Teresa|||0000-0001-7387-7389
  • Montaner, Joan|||0000-0003-4845-2279
Stroke is the fifth leading cause of death and the most frequent cause of disability worldwide. Currently, stroke diagnosis is based on neuroimaging; therefore, the lack of a rapid tool to diagnose stroke is still a major concern. In addition, therapeutic approaches to combat ischemic stroke are still scarce, since the only approved therapies are directed toward restoring blood flow to the affected brain area. However, due to the reduced time window during which these therapies are effective, few patients benefit from them; therefore, alternative treatments are urgently needed to reduce stroke brain damage in order to improve patients' outcome. The inflammatory response triggered after the ischemic event plays an important role in the progression of stroke; consequently, the study of inflammatory molecules in the acute phase of stroke has attracted increasing interest in recent decades. Here, we provide an overview of the inflammatory processes occurring during ischemic stroke, as well as the potential for these inflammatory molecules to become stroke biomarkers and the possibility that these candidates will become interesting neuroprotective therapeutic targets to be blocked or stimulated in order to modulate inflammation after stroke.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro, Laura|||0000-0002-4121-4609
  • Abraira del Fresno, Laura|||0000-0002-5119-7929
  • Quintana, Manuel|||0000-0003-0288-9088
  • García-Rodríguez, Paula|||0000-0001-6596-8002
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Zaragoza, Josep
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Ustrell, Xavier
  • Lara-Rodríguez, Blanca|||0009-0003-4534-9687
  • Terceño, Mikel|||0000-0001-5532-5329
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Montaner, Joan|||0000-0003-4845-2279
Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z -scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

  • Ramiro, Laura|||0000-0002-4121-4609
  • Faura, Júlia|||0000-0002-8436-1377
  • Simats Oriol, Alba|||0000-0002-0415-1135
  • García-Rodríguez, Paula|||0000-0001-6596-8002
  • Ma, Feifei|||0000-0003-1321-5564
  • Martín, Luna
  • Canals, Francesc|||0000-0002-0650-1135
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Montaner, Joan|||0000-0003-4845-2279
The online version contains supplementary material available at 10.1186/s12868-023-00775-7.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

  • Ramiro Pascual, Laura
  • Faura Llorens, Julia
  • Garcia Rodriguez, Paula
  • Ma, Feifei
  • Martín Castel, Luna
  • Canals Suris, Francesc
  • Montaner Villalonga, Joan
  • Rosell Novel, Anna
  • Simats Oriol, Alba
Diabetes; Proteome; Sex, Diabetis; Proteoma; Sexe, Diabetes; Proteoma; Sexo, Ischemic stroke is a major cause of death and disability worldwide. Translation into the clinical setting of neuroprotective agents showing promising results in pre-clinical studies has systematically failed. One possible explanation is that the animal models used to test neuroprotectants do not properly represent the population affected by stroke, as most of the pre-clinical studies are performed in healthy young male mice. Therefore, we aimed to determine if the response to cerebral ischemia differed depending on age, sex and the presence of comorbidities. Thus, we explored proteomic and transcriptomic changes triggered during the hyperacute phase of cerebral ischemia (by transient intraluminal middle cerebral artery occlusion) in the brain of: (1) young male mice, (2) young female mice, (3) aged male mice and (4) diabetic young male mice. Moreover, we compared each group's proteomic and transcriptomic changes using an integrative enrichment pathways analysis to disclose key common and exclusive altered proteins, genes and pathways in the first stages of the disease. We found 61 differentially expressed genes (DEG) in male mice, 77 in females, 699 in diabetics and 24 in aged mice. Of these, only 14 were commonly dysregulated in all groups. The enrichment pathways analysis revealed that the inflammatory response was the biological process with more DEG in all groups, followed by hemopoiesis. Our findings indicate that the response to cerebral ischemia regarding proteomic and transcriptomic changes differs depending on sex, age and comorbidities, highlighting the importance of incorporating animals with different phenotypes in future stroke research studies., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by the European Regional Development Fund (FEDER). Neurovascular Research Laboratory takes part in the Spanish stroke research network RICORS-ICTUS. L.R is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro Pascual, Laura
  • Quintana Luque, Manuel
  • Garcia Rodriguez, Paula
  • Santamarina Pérez, Estevo
  • Alvarez Sabin, José
  • Bustamante Rangel, Alejandro
  • Montaner Villalonga, Joan
  • Abraira del Fresno, Laura
Biomarcador; Endostatina; Accident cerebrovascular isquèmic, Biomarcador; Endostatina; Accidente cerebrovascular isquémico, Biomarker; Endostatin; Ischemic stroke, Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z-scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin > quartile 2, tumor necrosis factor receptor-1 (TNF-R1) > quartile 2, and interleukin (IL)-6 > quartile 2. The risk of mortality when these three biomarkers were combined increased up to 69%. The addition of the biomarkers to clinical predictors improved the discrimination (integrative discriminative improvement (IDI) 0.022 (0.007–0.048), p < 0.001). Moreover, endostatin > quartile 3 was an independent predictor of mortality due to stroke. Altogether, endostatin, TNF-R1, and IL-6 circulating levels may aid in long-term mortality prediction after stroke., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by La Fundació La Marató (Reg. 84/240 proj. 201702). Neurovascular Research Laboratory takes part in the Spanish stroke research network INVICTUS+ (RD16/0019/0021). L.R. is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).